Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Stevenson

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Current Vascular Pharmacology|March 2, 2019
Premature Ovarian Insufficiency and Long-Term Health ConsequencesSophia Tsiligiannis, Nick Panay, John C Stevenson
Current Vascular Pharmacology|October 4, 2018
Cardiovascular Risk in Perimenopausal WomenJohn C Stevenson, Sophia Tsiligiannis, Nick Panay
Climacteric : the Journal of the International Menopause Society|July 9, 2021
David McKay Hart, MD, FRCS (Glasgow), FRCOGJohn C Stevenson, Keith J M Spowart
Maturitas|July 10, 2013
Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safetyJohn C Stevenson, Nicholas Panay, Claire Pexman-Fieth
Post Reproductive Health|May 28, 2024
Hormone replacement therapy after myocardial infarction: British Menopause Society Tool for CliniciansJohn C Stevenson, Peter Collins, Howard N Hodis, et al.
Surgical Technology International|October 2, 2013
Outcomes and complications following spinous process fixation: a single-center analysis of 192 casesRanjith Babu, Oren N Gottfried, John C Stevenson
Clinical Endocrinology|April 12, 2019
Independent relationships between bone mineral density, regional body fat and insulin sensitivity in white malesWann Jia Loh, John C Stevenson, Ian F Godsland
Maturitas|August 7, 2010
Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled studyJohn C Stevenson, Gemma Durand, Elke Kahler, et al.
Maturitas|April 21, 2015
Misrepresentation of the risk of ovarian cancer among women using menopausal hormones. Spurious findings in a meta-analysisSamuel Shapiro, John C Stevenson, Alfred O Mueck, et al.
Clinical Endocrinology|January 10, 2003
Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal womenAnthony J Proudler, Alison Cooper, Malcolm Whitehead, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Current Vascular Pharmacology|March 2, 2019
Premature Ovarian Insufficiency and Long-Term Health ConsequencesSophia Tsiligiannis, Nick Panay, John C Stevenson
Current Vascular Pharmacology|October 4, 2018
Cardiovascular Risk in Perimenopausal WomenJohn C Stevenson, Sophia Tsiligiannis, Nick Panay
Climacteric : the Journal of the International Menopause Society|July 9, 2021
David McKay Hart, MD, FRCS (Glasgow), FRCOGJohn C Stevenson, Keith J M Spowart
Maturitas|July 10, 2013
Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safetyJohn C Stevenson, Nicholas Panay, Claire Pexman-Fieth
Post Reproductive Health|May 28, 2024
Hormone replacement therapy after myocardial infarction: British Menopause Society Tool for CliniciansJohn C Stevenson, Peter Collins, Howard N Hodis, et al.
Surgical Technology International|October 2, 2013
Outcomes and complications following spinous process fixation: a single-center analysis of 192 casesRanjith Babu, Oren N Gottfried, John C Stevenson
Clinical Endocrinology|April 12, 2019
Independent relationships between bone mineral density, regional body fat and insulin sensitivity in white malesWann Jia Loh, John C Stevenson, Ian F Godsland
Maturitas|August 7, 2010
Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled studyJohn C Stevenson, Gemma Durand, Elke Kahler, et al.
Maturitas|April 21, 2015
Misrepresentation of the risk of ovarian cancer among women using menopausal hormones. Spurious findings in a meta-analysisSamuel Shapiro, John C Stevenson, Alfred O Mueck, et al.
Clinical Endocrinology|January 10, 2003
Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal womenAnthony J Proudler, Alison Cooper, Malcolm Whitehead, et al.
Pageof 10